X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (47) 47
index medicus (28) 28
pharmacology & pharmacy (22) 22
cocaine (17) 17
male (17) 17
cell line (16) 16
dopamine plasma membrane transport proteins (16) 16
dopamine transporter (16) 16
neurosciences (16) 16
biochemistry & molecular biology (15) 15
dopamine - metabolism (15) 15
dose-response relationship, drug (15) 15
membrane glycoproteins (15) 15
middle aged (15) 15
female (13) 13
pharmacokinetics (13) 13
thalidomide - analogs & derivatives (13) 13
adult (12) 12
human necessities (12) 12
hygiene (12) 12
medical or veterinary science (12) 12
preparations for medical, dental, or toilet purposes (12) 12
aged (11) 11
oncology (11) 11
specific therapeutic activity of chemical compounds ormedicinal preparations (11) 11
chemistry (10) 10
cocaine - analogs & derivatives (10) 10
membrane transport proteins - metabolism (10) 10
metallurgy (10) 10
nerve tissue proteins (10) 10
organic chemistry (10) 10
peptides (10) 10
animals (9) 9
dopamine (9) 9
kinetics (9) 9
lenalidomide (9) 9
medicine & public health (9) 9
pharmacology (9) 9
serotonin transporter (9) 9
binding (8) 8
human norepinephrine transporter (8) 8
pharmacology/toxicology (8) 8
thalidomide - pharmacokinetics (8) 8
young adult (8) 8
amphetamine (7) 7
binding, competitive - drug effects (7) 7
cancer research (7) 7
cocaine - metabolism (7) 7
cocaine - pharmacology (7) 7
inhibition (7) 7
kidney - metabolism (7) 7
multiple myeloma (7) 7
neurotransmitter transporters (7) 7
analysis (6) 6
antineoplastic agents - pharmacokinetics (6) 6
care and treatment (6) 6
carrier proteins - metabolism (6) 6
dopamine - pharmacokinetics (6) 6
dopamine uptake inhibitors - pharmacology (6) 6
drug interactions (6) 6
nab-paclitaxel (6) 6
nerve tissue proteins - metabolism (6) 6
paclitaxel (6) 6
plus dexamethasone (6) 6
research (6) 6
sodium - metabolism (6) 6
sodium - pharmacology (6) 6
thalidomide - administration & dosage (6) 6
thalidomide - adverse effects (6) 6
adolescent (5) 5
biochemistry (5) 5
cell membrane - metabolism (5) 5
cocaine - pharmacokinetics (5) 5
cross-linking (5) 5
dopamine plasma membrane transport proteins - metabolism (5) 5
dosage and administration (5) 5
kidney - cytology (5) 5
membrane transport proteins (5) 5
models, molecular (5) 5
neoplasms - drug therapy (5) 5
phenols (5) 5
protein binding - drug effects (5) 5
protein conformation (5) 5
release (5) 5
renal impairment (5) 5
thalidomide - pharmacology (5) 5
time factors (5) 5
tumors (5) 5
accessibility (4) 4
aged, 80 and over (4) 4
area under curve (4) 4
article (4) 4
benztropine (4) 4
biological transport (4) 4
biological transport - drug effects (4) 4
cancer (4) 4
carrier proteins - chemistry (4) 4
carrier proteins - genetics (4) 4
cell membrane - drug effects (4) 4
cells, cultured (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Clinical Pharmacology, ISSN 0091-2700, 10/2014, Volume 54, Issue 10, pp. 1097 - 1107
Journal Article
Journal of Clinical Pharmacology, ISSN 0091-2700, 08/2019
A population pharmacokinetic (PPK) model to describe the pharmacokinetics of thalidomide in different patient populations was developed using data pooled from... 
Journal Article
Journal Article
Journal of Small Business Management, ISSN 0047-2778, 01/2018, Volume 56, Issue 1, pp. 179 - 201
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 10/2015, Volume 76, Issue 4, pp. 699 - 712
nab-paclitaxel demonstrates improved clinical efficacy compared with conventional Cremophor EL (CrEL)-paclitaxel in multiple tumor types. This study explored... 
Cremophor EL | Medicine & Public Health | Nanoparticle | Albumin | Oncology | Cancer Research | Taxane | Pharmacology/Toxicology | nab -paclitaxel | nab-paclitaxel | COLONY-STIMULATING FACTOR | SOLID TUMORS | PANCREATIC-CANCER | NONLINEAR PHARMACOKINETICS | PHASE-III TRIAL | BREAST-CANCER | ONCOLOGY | ENDOTHELIAL-CELLS | IN-VIVO | PHARMACOLOGY & PHARMACY | SOLVENT-BASED PACLITAXEL | CREMOPHOR EL MICELLES | Endothelium, Vascular - cytology | Paclitaxel - metabolism | Pancreatic Neoplasms - metabolism | Human Umbilical Vein Endothelial Cells - metabolism | Nanoparticles - chemistry | Humans | Capillary Permeability - drug effects | Endothelium, Vascular - drug effects | Paclitaxel - pharmacokinetics | Endosomes - metabolism | Serum Albumin, Human | Drug Delivery Systems | Pancreatic Neoplasms - drug therapy | Tissue Distribution | Antineoplastic Agents, Phytogenic - administration & dosage | Human Umbilical Vein Endothelial Cells - cytology | Endosomes - drug effects | Tubulin Modulators - administration & dosage | Tubulin Modulators - metabolism | Antineoplastic Agents, Phytogenic - metabolism | Biological Transport - drug effects | Antineoplastic Agents, Phytogenic - therapeutic use | Carcinoma - pathology | Paclitaxel - administration & dosage | Serum Albumin - chemistry | Antineoplastic Agents, Phytogenic - pharmacokinetics | Carcinoma - drug therapy | Human Umbilical Vein Endothelial Cells - drug effects | Microinjections | Tubulin Modulators - pharmacokinetics | Pancreatic Neoplasms - pathology | Cells, Cultured | Endosomes - pathology | Paclitaxel - therapeutic use | Tubulin Modulators - therapeutic use | Xenograft Model Antitumor Assays | Animals | Endothelium, Vascular - metabolism | Mice, Nude | Cell Line, Tumor | Endothelium, Vascular - pathology | Carcinoma - metabolism | Infusions, Intravenous | Serum Albumin - metabolism | Antimitotic agents | Dimethyl sulfoxide | Exhibitions | Permeability | Antineoplastic agents | Tumors | Index Medicus | Original
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2016, Volume 78, Issue 1, pp. 173 - 182
Journal Article
Journal of Small Business Management, ISSN 0047-2778, 01/2018, Volume 56, Issue 1, pp. 179 - 201
We use Resource Dependency Theory and Human Capital Theory to explain entrepreneurship research, which is a relatively new research field over the last decade.... 
GOOGLE SCHOLAR | MANAGEMENT | EMERGING FORUM | FINANCE | FIELD | KNOWLEDGE | EDUCATION | JOURNALS | SCIENCE | EMERGENCE | TRENDS | Entrepreneurship | Analysis | Research | Citation analysis | Collaboration | Dependency theory
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 3234 - 3234
Abstract Introduction Lenalidomide (LEN) has been approved for the treatment of multiple myeloma (MM: dose 25mg/day, in combination with dexamethasone),... 
Journal Article
International Journal of Hematology, ISSN 0925-5710, 6/2015, Volume 101, Issue 6, pp. 569 - 577
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1990 - 1990
Abstract Background: Luspatercept is a modified ActRIIB-IgG Fc fusion protein that corrects ineffective erythropoiesis. In phase 2 studies, luspatercept... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2463 - 2463
Abstract Background: In β-thalassemia, imbalanced production of α and β globin chains in erythroid precursors inhibits late-stage erythroid differentiation,... 
Journal Article
Molecular pharmaceutics, ISSN 1543-8384, 05/2019, Volume 16, Issue 6, pp. 2385 - 2393
nab-Paclitaxel ( nab-P), an albumin-bound formulation of paclitaxel, was developed to improve the tolerability and antitumor activity of taxanes. The neonatal... 
Journal Article
Clinical Pharmacology in Drug Development, ISSN 2160-763X, 06/2018, Volume 7, Issue 5, pp. 465 - 473
A population pharmacokinetic (PopPK) model of lenalidomide was developed using data pooled from 13 clinical studies (dose range, 5–400 mg) in participants who... 
multiple myeloma | cancer | lenalidomide | population pharmacokinetics | REFRACTORY MULTIPLE-MYELOMA | EFFICACY | RENAL IMPAIRMENT | POMALIDOMIDE | PLUS DEXAMETHASONE | METABOLISM | MEN | PHARMACOLOGY & PHARMACY | PHASE-I | MYELODYSPLASTIC SYNDROMES
Journal Article